What Change in Body Mass Index Is Required to Improve Cardiovascular Outcomes in Childhood and Adolescent Obesity through Lifestyle Interventions: A Meta-Regression
Restricted accessReview articleFirst published online October, 2020
What Change in Body Mass Index Is Required to Improve Cardiovascular Outcomes in Childhood and Adolescent Obesity through Lifestyle Interventions: A Meta-Regression
Using meta-regression, this article aims at establishing the minimum change in BMI-standard deviation score (SDS) needed to improve lipid profiles and blood pressure in children and adolescents with obesity, to aid future trials and guidelines.
Methods:
Studies with participants involved in lifestyle interventions, aged 4–19 years, with a diagnosis of obesity according to defined BMI thresholds, were considered for inclusion in a large systematic review. Interventions had to report pre- and post-intervention (or mean change in) BMI-SDS, plus either systolic blood pressure (SBP), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and/or triglycerides (TGs). Random-effects meta-regression quantified the relationship between mean change in BMI-SDS and mean change in cardiovascular outcomes.
Results:
Seventy-one papers reported various cardiovascular measurements and mean change in BMI-SDS. Fifty-four, 59, 46, and 54 studies were analyzed, reporting a change in SBP, HDL, LDL, and TG, respectively. Reduction in mean BMI-SDS was significantly related to improvements in SBP, LDL, TG, and HDL (p < 0.05); BMI-SDS reductions of 1, 1.2, and 0.7 ensured a mean reduction of SBP, LDL, and TG, respectively, although an equivalent value for HDL improvement was indeterminate.
Conclusion:
Reductions in mean BMI-SDS of >1, >1.2, or >0.7 are likely to reduce SBP, LDL, and TG, respectively. Further studies are needed to clarify the optimal duration, intensity, and setting for interventions. Consistency is required regarding derived BMI values to facilitate future systematic reviews and meta-analyses.
Get full access to this article
View all access options for this article.
References
1.
World Health Organization. World health statistics 2016: monitoring health for the SDGs sustainable development goals. World Health Organization. June 8, 2016.
2.
PearceM, Webb-PhillipsS, BrayI. Changes in objectively measured BMI in children aged 4–11 years: Data from the National Child Measurement Programme. J Public Health, 2016; 38:459–466.
3.
FreedmanDS, DietzWH, TangR, et al.The relation of obesity throughout life to carotid intima-media thickness in adulthood: The Bogalusa Heart Study. Int J Obes, 2004; 28:159.
4.
SimmondsM, LlewellynA, OwenCG, WoolacottN. Predicting adult obesity from childhood obesity: A systematic review and meta-analysis. Obes Rev, 2016; 17:95–107.
5.
Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA, 1990; 264:3018–3024.
6.
BerensonGS, SrinivasanSR, BaoW, et al.Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med, 1998; 338:1650–1656.
7.
LiS, ChenW, SrinivasanSR, et al.Childhood cardiovascular risk factors and carotid vascular changes in adulthood: The Bogalusa Heart Study. JAMA, 2003; 290:2271–2276.
8.
MagnussenCG, VennA, ThomsonR, et al.The association of pediatric low-and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood: Evidence from the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study, and the CDAH (Childhood Determinants of Adult Health) Study. J Am Coll Cardiol, 2009; 53:860–869.
9.
LauerRM, ClarkeWR, BeagleholeR. Level, trend, and variability of blood pressure during childhood: The Muscatine study. Circulation, 1984; 69:242–249.
10.
DavisPH, DawsonJD, RileyWA, LauerRM. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation, 2001; 104:2815–2819.
11.
RaitakariOT, JuonalaM, RönnemaaT, et al.Cohort profile: The cardiovascular risk in Young Finns Study. Int J Epidemiol, 2008; 37:1220–1226.
12.
MagkosF, FraterrigoG, YoshinoJ, et al.Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metabolism, 2016; 23:591–601.
13.
JensenMD, RyanDH, ApovianCM, et al.2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol, 2014; 63(25 Part B):2985–3023.
14.
LogueJ, ThompsonL, RomanesF, et al.Management of obesity: Summary of SIGN guideline. BMJ, 2010; 340:c154.
15.
ReinehrT, LassN, ToschkeC, et al.Which amount of BMI-SDS reduction is necessary to improve cardiovascular risk factors in overweight children?. J Clin Endocrinol Metab, 2016; 101:3171–3179.
16.
FordAL, HuntLP, CooperA, ShieldJP. What reduction in BMI SDS is required in obese adolescents to improve body composition and cardiometabolic health?. Arch Dis Child, 2010; 95:256–261.
17.
WunschR, de SousaG, ToschkeAM, ReinehrT. Intima-media thickness in obese children before and after weight loss. Pediatrics, 2006; 118:2334–2340.
18.
ColeTJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr, 1990; 44:45–60.
19.
BrannsetherB, EideGE, RoelantsM, et al.BMI and BMI SDS in childhood: Annual increments and conditional change. Ann Hum Biol, 2017; 44:28–33.
20.
PoskittEM. Defining childhood obesity: The relative body mass index (BMI). Acta Paediatr, 1995; 84:961–963.
21.
Oude LuttikhuisH, BaurL, JansenH, et al.Cochrane review: Interventions for treating obesity in children. Evidence-based child health. Cochrane Rev J, 2009; 4:1571–1729.
22.
HoM, GarnettSP, BaurL, et al.Effectiveness of lifestyle interventions in child obesity: Systematic review with meta-analysis. Pediatrics, 2012; 130:e1647–e1671.
23.
ColquittJL, LovemanE, O'MalleyC, et al.Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years. Cochrane Database Syst Rev, 2016; 10:CD012105.
24.
LobsteinT, BaurL, UauyR. Obesity in children and young people: A crisis in public health. Obes Rev, 2004; 5:4–85.
25.
HannonTS, RaoG, ArslanianSA. Childhood obesity and type 2 diabetes mellitus. Pediatrics, 2005; 116:473–480.
26.
UrbinaEM, WilliamsRV, AlpertBS, et al.Noninvasive assessment of subclinical atherosclerosis in children and adolescents: Recommendations for standard assessment for clinical research: A scientific statement from the American Heart Association. Hypertension, 2009; 54:919–950.
27.
PiresA, MartinsP, PereiraAM, et al. Insulin resistance, dyslipidemia and cardiovascular changes in a group of obese children. Arq Bras Cardiol 2014(AHEAD).
28.
CookS, KaveyRE. Dyslipidemia and pediatric obesity. Pediatr Clinics, 2011; 58:1363–1373.
29.
ChiarelliF, MarcovecchioML. Insulin resistance and obesity in childhood. Eur J Endocrinol, 2008; 159(suppl_1):S67–S74.
30.
TounianP, AggounY, DubernB, et al.Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: A prospective study. Lancet, 2001; 358:1400–1404.
31.
BirchL, PerryR, HuntLP, et al.What change in body mass index is associated with improvement in percentage body fat in childhood obesity? A meta-regression. BMJ Open, 2019; 9:e028231.
32.
MatsonRI, PerryR, HuntLP, et al.Change in obesity-related metabolic abnormalities associated with BMI improvement through life-style intervention: A meta-regression. Pediatr Diabetes, 2020; 21:173–193.
33.
MoherD, LiberatiA, TetzlaffJ, et al.Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. 2009; 89:873–880.
34.
BirchL, PerryR, PenfoldC, et al.What change in body mass index is needed to improve metabolic health status in childhood obesity: Protocol for a systematic review. Syst Rev, 2016; 5:120.
35.
HigginsJ, GreenS. Cochrane Handbook for Systematic Reviews of Interventions.Chichester: Wiley, 2011.
36.
AvenellA, BroomJ, BrownTJ. Systematic review of the long-term outcomes of the treatments for obesity and implications for health improvement and the economic consequences for the National Health Service. Health Technol Assess, 2004; 4:iii–iv, 1–182.
37.
HarbordRM, HigginsJP. Meta-regression in Stata. Stata J, 2008; 8:493–519.
38.
ThompsonSG, HigginsJP. How should meta-regression analyses be undertaken and interpreted?. Stat Med, 2002; 21:1559–1573.
39.
UysalY, WoltersB, KnopC, ReinehrT. Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention. Clin Nutr, 2014; 33:620–625.
40.
ReinehrT, de SousaG, WabitschM. Changes of cardiovascular risk factors in obese children effects of inpatient and outpatient interventions. J Pediatr Gastroenterol Nutr, 2006; 43:506–511.
41.
BeanMK, MazzeoSE, SternM, et al.Six-month dietary changes in ethnically diverse, obese adolescents participating in a multidisciplinary weight management program. Clin Pediatr, 2011; 50:408–416.
42.
BellLM, WattsK, SiafarikasA, et al.Exercise alone reduces insulin resistance in obese children independently of changes in body composition. J Clin Endocrinol Metab, 2007; 92:4230–4235.
43.
BockDE, RobinsonT, SeabrookJA, et al.The Health Initiative Program for Kids (HIP Kids): Effects of a 1-year multidisciplinary lifestyle intervention on adiposity and quality of life in obese children and adolescents-a longitudinal pilot intervention study. BMC Pediatr, 2014; 14:296.
44.
BoodaiSA, McCollJH, ReillyJJ. National Adolescent Treatment Trial for Obesity in Kuwait (NATTO): Project design and results of a randomised controlled trial of a good practice approach to treatment of adolescent obesity in Kuwait. Trials, 2014; 15:234.
45.
BruyndonckxL, HoymansVY, De GuchtenaereA, et al.Diet, exercise, and endothelial function in obese adolescents. Pediatrics, 2015; 135:e653–e661.
46.
BustosP, OriasJ, SáezK, et al.Effects of the Bright Bodies Program in Chilean obese children. Rev Med Chil, 2015; 143:1136–1143.
47.
CalcaterraV, LarizzaD, CodronsE, et al.Improved metabolic and cardiorespiratory fitness during a recreational training program in obese children. J Pediatr Endocrinol Metab, 2013; 26:271–276.
48.
CorripioR, Gónzalez-ClementeJM, Pérez-SánchezJ, et al.Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: A 2-year longitudinal study. Eur J Endocrinol, 2010; 163:887–893.
49.
CrokerH, VinerRM, NichollsD, et al.Family-based behavioural treatment of childhood obesity in a UK National Health Service setting: Randomized controlled trial. Int J Obes, 2012; 36:16.
50.
DobeM, GeislerA, HoffmannD, et al.The Obeldicks concept. An example for a successful outpatient lifestyle intervention for overweight or obese children and adolescents]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2011; 54:628–635.
51.
DoughtyKN, NjikeVY, KatzDL. Effects of a cognitive-behavioral therapy-based immersion obesity treatment program for adolescents on weight, fitness, and cardiovascular risk factors: A pilot study. Child Obes, 2015; 11:215–218.
52.
EvansRK, FrancoRL, SternM, et al.Evaluation of a 6-month multi-disciplinary healthy weight management program targeting urban, overweight adolescents: Effects on physical fitness, physical activity, and blood lipid profiles. Int J Pediatr Obes, 2009; 4:130–133.
53.
Farpour-LambertNJ, AggounY, MarchandLM, et al.Physical activity reduces systemic blood pressure and improves early markers of atherosclerosis in pre-pubertal obese children. J Am Coll Cardiol, 2009; 54:2396–2406.
54.
GajewskaJ, KuryłowiczA, MierzejewskaE, et al.Complementary effects of genetic variations in LEPR on body composition and soluble leptin receptor concentration after 3-month lifestyle intervention in prepubertal obese children. Nutrients, 2016; 8:328.
55.
Garanty-BogackaB, SyreniczM, GoralJ, et al.Changes in inflammatory biomarkers after successful lifestyle intervention in obese children. Endokrynol Pol, 2011; 62:499–505.
56.
GrønbækH, LangeA, BirkebækNH, et al.Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. J Pediatr Gastroenterol Nutrit, 2012; 54:223–228.
57.
KazankovK, MøllerHJ, LangeA, et al.The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children. Pediatr Obes, 2015; 10:226–233.
58.
Grulich-HennJ, LichtensteinS, HörsterF, et al.Moderate weight reduction in an outpatient obesity intervention program significantly reduces insulin resistance and risk factors for cardiovascular disease in severely obese adolescents. Int J Endocrinol, 2011; 2011:541021.
59.
GunnarsdottirT, EinarssonSM, NjardvikU, et al.Family-based behavioral treatment for obese children-results and two year follow up. Laeknabladid, 2014; 100:139–145.
60.
HuangF, del-Río-NavarroBE, de CastroGT, et al.Weight loss induced by 6-month lifestyle intervention improves early endothelial activation and fibrinolysis in obese adolescents. Child Care Health Dev, 2011; 37:377–384.
61.
HuangF, del-Río-NavarroBE, Pérez-OntiverosJA, et al.Effect of six-month lifestyle intervention on adiponectin, resistin and soluble tumor necrosis factor-α receptors in obese adolescents. Endocr J, 2014; 61:921–931.
62.
HvidtKN, OlsenMH, HolmJC, IbsenH. Obese children and adolescents have elevated nighttime blood pressure independent of insulin resistance and arterial stiffness. Am J Hypertens, 2014; 27:1408–1415.
63.
KalavainenM, UtriainenP, VanninenE, et al.Impact of childhood obesity treatment on body composition and metabolic profile. World J Pediatr, 2012; 8:31–37.
64.
KirkS, ZellerM, ClaytorR, et al.The relationship of health outcomes to improvement in BMI in children and adolescents. Obes Res, 2005; 13:876–882.
65.
KolotourouM, RadleyD, ChadwickP, et al.Is BMI alone a sufficient outcome to evaluate interventions for child obesity?. Child Obes, 2013; 9:350–356.
66.
KolsgaardML, JonerG, BrunborgC, et al.Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo Adiposity Intervention Study—A hospital/public health nurse combined treatment. BMC Pediatr, 2011; 11:47.
67.
MagerDR, IñiguezIR, GilmourS, YapJ. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). J Parenter Enteral Nutr, 2015; 39:73–84.
68.
MakkesS, RendersCM, BosmansJE, et al.One-year effects of two intensive inpatient treatments for severely obese children and adolescents. BMC Pediatr, 2016; 16:120.
69.
MarcanoH, FernándezM, PaoliM, et al.Limited weight loss or simply no weight gain following lifestyle-only intervention tends to redistribute body fat, to decrease lipid concentrations, and to improve parameters of insulin sensitivity in obese children. Int J Pediatr Endocrinol, 2011; 2011:241703.
70.
MeyerAA, KundtG, LenschowU, et al.Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol, 2006; 48:1865–1870.
71.
MiragliaF, de Moraes SilveiraCR, Gomes BeghettoM, et al.Behavior of adipokines after a year follow-up in the obesity outpatient clinic for children and adolescents. Nutr Hosp, 2015; 32:1554–1559.
72.
MonteroD, WaltherG, Perez-MartinA, et al.Effects of a lifestyle program on vascular reactivity in macro-and microcirculation in severely obese adolescents. J Clin Endocrinol Metab, 2014; 99:1019–1026.
73.
Morell-AzanzaL, García-CalzónS, Rendo-UrteagaT, et al.Serum oxidized low-density lipoprotein levels are related to cardiometabolic risk and decreased after a weight loss treatment in obese children and adolescents. Pediatr Diabetes, 2017; 18:392–398.
74.
Rendo-UrteagaT, García-CalzónS, González-MuniesaP, et al.Peripheral blood mononuclear cell gene expression profile in obese boys who followed a moderate energy-restricted diet: Differences between high and low responders at baseline and after the intervention. Br J Nutr, 2015; 113:331–342.
75.
MurdoloG, TortoioliC, CeliF, et al.Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: A population-based survey in prepubertal schoolchildren. Endocrine, 2017; 56:357–365.
76.
MurerSB, KnöpfliBH, AeberliI, et al.Baseline leptin and leptin reduction predict improvements in metabolic variables and long-term fat loss in obese children and adolescents: A prospective study of an inpatient weight-loss program. Am J Clin Nutr, 2011; 93:695–702.
77.
AeberliI, JungA, MurerSB, et al.During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat. J Clin Endocrinol Metab, 2010; 95:5412–5418.
78.
ObertP, GueugnonC, NottinS, et al.Impact of diet and exercise training-induced weight loss on myocardial mechanics in severely obese adolescents. Obesity, 2013; 21:2091–2098.
79.
PacificoL, ArcaM, AnaniaC, et al.Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis, 2013; 23:1010–1016.
80.
ParilloM, LicenziatiMR, VaccaM, et al.Metabolic changes after a hypocaloric, low-glycemic-index diet in obese children. J Endocrinol Invest, 2012; 35:629–633.
81.
RacilG, OunisOB, HammoudaO, et al.Effects of high vs. moderate exercise intensity during interval training on lipids and adiponectin levels in obese young females. Eur J Appl Physiol, 2013; 113:2531–2540.
82.
RacilG, CoquartJB, ElmontassarW, et al.Greater effects of high-compared with moderate-intensity interval training on cardio-metabolic variables, blood leptin concentration and ratings of perceived exertion in obese adolescent females. Biol Sport, 2016; 33:145.
83.
RambhojanC, Bouaziz-AmarE, LariflaL, et al.Ghrelin, adipokines, metabolic factors in relation with weight status in school-children and results of a 1-year lifestyle intervention program. Nutr Metab, 2015; 12:43.
84.
ReinehrT, AndlerW. Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child, 2004; 89:419–422.
85.
ReinehrT, de SousaG, ToschkeAM, AndlerW. Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am J Clin Nutr, 2006; 84:490–496.
86.
ReinehrT, RothCL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab, 2008; 93:4479–4485.
87.
ReinehrT, Stoffel-WagnerB, RothCL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab, 2008; 93:2287–2293.
88.
ReinehrT, KleberM, ToschkeAM. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis, 2009; 207:174–180.
89.
ReinehrT, ElfersC, LassN, RothCL. Irisin and its relation to insulin resistance and puberty in obese children: A longitudinal analysis. J Clin Endocrinol Metab, 2015; 100:2123–2130.
90.
RijksJM, PlatJ, MensinkRP, et al.Children with morbid obesity benefit equally as children with overweight and obesity from an ongoing care program. J Clin Endocrinol Metab, 2015; 100:3572–3580.
91.
RohrerTR, RizzoVF, CäsarJJ, et al.Changes in hepatic risk factors, metabolic variables, body composition, and physical fitness in obese children after a one-year weight loss program. J Pediatr Endocrinol Metab, 2008; 21:837–846.
92.
RothCL, KratzM, RalstonMM, ReinehrT. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism, 2011; 60:445–452.
93.
RothCL, ElfersC, LassN, ReinehrT. Betatrophin: No relation to glucose metabolism or weight status in obese children before and after lifestyle intervention. Pediatr Diabetes, 2017; 18:485–491.
94.
RoviraFA, MiroPN, Zaragoza-JordanaM, et al.Clinical and metabolic effectiveness of a new motivational therapy for the treatment of obesity in adolescents (OBEMAT). An Pediatr, 2013; 78:157–166.
95.
SantomauroM, Paoli-ValeriM, FernándezM, et al.Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: Effect of a one-year intervention on lifestyle. Endocrinol Nutr, 2012; 59:346–353.
96.
SavoyeM, NowickaP, ShawM, et al.Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics, 2011; 127:402.
97.
SavoyeM, ShawM, DziuraJ, et al.Effects of a weight management program on body composition and metabolic parameters in overweight children: A randomized controlled trial. JAMA, 2007; 297:2697–2704.
98.
SavoyeM, CaprioS, DziuraJ, et al.Reversal of early abnormalities in glucose metabolism in obese youth: Results of an intensive lifestyle randomized controlled trial. Diabetes care, 2014; 37:317–324.
99.
SeabraA, KatzmarzykP, CarvalhoMJ, et al.Effects of 6-month soccer and traditional physical activity programmes on body composition, cardiometabolic risk factors, inflammatory, oxidative stress markers and cardiorespiratory fitness in obese boys. Journal of sports sciences, 2016; 34:1822–1829.
100.
ShalitinS, Ashkenazi-HoffnungL, Yackobovitch-GavanM, et al.Effects of a twelve-week randomized intervention of exercise and/or diet on weight loss and weight maintenance, and other metabolic parameters in obese preadolescent children. Horm Res Paediatr, 2009; 72:287–301.
101.
Tan-TingAM, LlidoL. Outcome of a hospital based multidisciplinary weight loss program in obese Filipino children. Nutrition, 2011; 27:50–54.
102.
TrubyH, BaxterK, WareRS, et al.A randomized controlled trial of two different macronutrient profiles on weight, body composition and metabolic parameters in obese adolescents seeking weight loss. PLoS One, 2016; 11:e0151787.
103.
JiménezMV, MartosR, MoralesRM, et al.Relationship between changes in plasma leptin concentrations and plasminogen activator inhibitor-1 in obese prepubertal children after nine months of treatment. Ann Nutr Metab, 2013; 63:216–222.
104.
van der Baan-SlootwegO, BenningaMA, BeelenA, et al.Inpatient treatment of children and adolescents with severe obesity in the Netherlands: A randomized clinical trial. JAMA Pediatr, 2014; 168:807–814.
105.
Van HoorenbeeckK, FranckxH, DebodeP, et al.Metabolic disregulation in obese adolescents with sleep-disordered breathing before and after weight loss. Obesity, 2013; 21:1446–1450.
106.
VerduciE, RadaelliG, SalvioniM, et al.Plasma long-chain fatty acids profile and metabolic outcomes in normolipidaemic obese children after one-year nutritional intervention. Acta Paediatr, 2011; 100:585–589.
107.
PozzatoC, VerduciE, ScaglioniS, et al.Liver fat change in obese children after a 1-year nutrition-behavior intervention. J Pediatr Gastroenterol Nutr, 2010; 51:331–335.
108.
VerduciE, LassandroC, GiaccheroR, et al.Change in metabolic profile after 1-year nutritional-behavioral intervention in obese children. Nutrients, 2015; 7:10089–10099.
109.
VisuthranukulC, SirimongkolP, PrachansuwanA, et al.Low-glycemic index diet may imposrove insulin sensitivity in obese children. Pediatr Res, 2015; 78:567.
110.
VitolaBE, DeivanayagamS, SteinRI, et al.Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents. Obesity, 2009; 17:1744–1748.
111.
VosRC, WitJM, PijlH, HoudijkEC. Long-term effect of lifestyle intervention on adiposity, metabolic parameters, inflammation and physical fitness in obese children: A randomized controlled trial. Nutr Diabetes, 2011; 1:e9
112.
WeigelC, KokocinskiK, LedererP, et al.Childhood obesity: Concept, feasibility, and interim results of a local group-based, long-term treatment program. J Nutr Educ Behav, 2008; 40:369–373.
113.
WeissR, ShawM, SavoyeM, CaprioS. Obesity dynamics and cardiovascular risk factor stability in obese adolescents. Pediatr Diabetes, 2009; 10:360–367.
114.
TannerJM. Growth at adolescence: With a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity. 2nd edition. 1962.
115.
HaneyEM, HuffmanLH, BougatsosC, et al.Screening and treatment for lipid disorders in children and adolescents: Systematic evidence review for the US Preventive Services Task Force. Pediatrics, 2007; 120:e189–e214.
116.
VanderwallC, EickhoffJ, ClarkRR, CarrelAL. BMI z-score in obese children is a poor predictor of adiposity changes over time. BMC Pediatr, 2018; 18:187.
117.
JúlíussonPB, RoelantsM, BenestadB, et al.Severe obesity is a limitation for the use of body mass index standard deviation scores in children and adolescents. Acta Paediatr, 2018; 107:307–314.
118.
FreedmanDS, ButteNF, TaverasEM, et al.BMI z-scores are a poor indicator of adiposity among 2-to 19-year-olds with very high BMIs, NHANES 1999–2000 to 2013–2014. Obesity, 2017; 25:739–746.
119.
FraportiMI, AdamiFS, RosolenMD. Cardiovascular risk factors in children. Rev Port Cardiol, 2017; 36:699–70.
120.
Al-KhudairyL, LovemanE, ColquittJL, et al.Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years. Cochrane Database Sys Rev, 2017; 6:CD012691.
121.
MeadE, BrownT, ReesK, et al.Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years. Cochrane Database Syst Rev, 2017; 6:CD012651.
122.
FreedmanDS, KhanLK, SerdulaMK, et al.The relation of childhood BMI to adult adiposity: The Bogalusa Heart Study. Pediatrics, 2005; 115:22–27.
123.
BakerJL, OlsenLW, SørensenTI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med, 2007; 357:2329–2337.
124.
BurkeV, BeilinLJ, SimmerK, et al.Predictors of body mass index and associations with cardiovascular risk factors in Australian children: A prospective cohort study. Int J Obes, 2005; 29:15.
125.
SavvaSC, TornaritisM, SavvaME, et al.Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes, 2000; 24:1453.
126.
DanielsSR, KhouryPR, MorrisonJA. The utility of body mass index as a measure of body fatness in children and adolescents: Differences by race and gender. Pediatrics, 1997; 99:804–807.
127.
SacksD, Canadian PaediatricSociety, Adolescent HealthCommittee. Age limits and adolescents. Paediatr Child Health, 2003; 8:577–578.
128.
ColeTJ, FreemanJV, PreeceMA. Body mass index reference curves for the UK, 1990. Arch Dis Child, 1995; 73:25–29.
129.
KuczmarskiRJ. CDC growth charts: United States. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2000.
130.
ColeTJ, LobsteinT. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes, 2012; 7:284–294.
131.
De OnisM, GarzaC, OnyangoAW, BorghiE. Comparison of the WHO child growth standards and the CDC 2000 growth charts. J Nutr, 2007; 137:144–148.
132.
OnisMD, OnyangoAW, BorghiE, et al.Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ, 2007; 85:660–667.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
